Benefits of reperfusion beyond infarct size limitation

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 269-276

  Takemura, Genzou ^a   Nakagawa, Munehiro ^a   Kanamori, Hiromitsu ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Infarct tissue dynamics; Late reperfusion; Left ventricular remodelling; Myocardial infarction; Open artery hypothesis

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CORONARY STENT; DRUG ELUTING STENT; DYNAMICS; HEART ANEURYSM; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE SIZE; HEART MUSCLE; HEART MUSCLE NECROSIS; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; REPERFUSION; REVASCULARIZATION; REVIEW; SCAR; ST SEGMENT ELEVATION; TISSUE REPAIR; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 67650242012     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp032     Document Type: Review

References (90)

1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 1995;46:455-466.
2. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993;72:13G-21G.
3. Forrester JS, Wyatt HL, Da Luz PL, Tyberg JV, Diamond GA, Swan HJ. Functional significance of regional ischemic contraction abnormalities. Circulation 1976;54:64-70.
4. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multi- variate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59:421- 430.
5. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
6. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89:68-75.
7. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994; 89:61-67.
8. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 1993;88:2426- 2436.
9. Marroquin OC, Lamas GA. Beneficial effects of an open artery on left ventricular remodeling after myocardial infarction. Prog Cardiovasc Dis 2004;42:471-483.
10. Yousef ZR, Marber MS. The open artery hypothesis: potential mechanisms of action. Prog Cardiovasc Dis 2000;42:419-438.
11. Sadanandan S, Hochman JS. Early reperfusion, late reperfusion, and the open artery hypothesis: an overview. Prog Cardiovasc Dis 2000;42:397-404.
12. Abbate A, Biondi-Zoccai GG, Baldi A, Trani C, Biasucci LM, Vetrovec GW. The 'Open-Artery Hypothesis': new clinical and pathophysiologic insights. Cardiology 2003;100:196-206.
13. Centurién OA. The open artery hypothesis: beneficial effects and long- term prognostic importance of patency of the infarct-related coronary artery. Angiology 2007;58:34-44.
14. Brueck M, Bandorski D, Kramer W, Vogt PR, Heidt MC. The late open infarct-related artery hypothesis: evidence-based medicine or not? Clin Cardiol 2007;30:541-545.
15. Elmariah S, Smith SC Jr, Fuster V. Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2008;5:42-52.
16. Mallory CK, White PD, Sacedo-Salger J. The speed of healing of myocar- dial infarction. A study of pathologic anatomy in seventy-two cases. Am Heart J 1939;18:647-671.
17. Lodge-Patch I. The aging of cardiac infarcts and its influence on cardiac rupture. Br Heart J 1951;13:37-42.
18. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978;90:57-70.
19. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53: 31-47.
20. Cleutjens JPM. The role of matrix metalloproteinases in heart disease. Cardiovasc Res 1996;32: 816-821.
21. Bing RJ. Myocardial ischemia and infarction: growth of ideas. Cardiovasc Res 2001;51:13-20.
22. Murry CE, Giachelli CM, Schwartz SM, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994;145:1450-1462.
23. CasscellsW, Kimura H, Sanchez JA, Yu ZX, FerransVJ. Immunohistochem- ical study of fibronectin in experimental myocardial infarction. Am J Pathol 1990;137:801-810.
24. Willems IE, Arends JW, Daemen MJ. Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 1996;179:321-325.
25. Ulrich MM, Janssen AM, Daemen MJ, Rappaport L, Samuel JL, Contard F et al. Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol 1997;29:2533-2543.
26. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
27. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanoh M, Ohno A et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 1998;82:1130-1138.
28. Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003;163: 2433-2440.
29. Jugdutt BI, Amy RWM. Healing after myocardial infarction in the dog: changes in infarct hydroyproline and topography. J Am Coll Cardiol 1986;7:91-102.
30. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 1988; 116: 1508-1513.
31. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000; 46:250-256.
32. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis 1987; 30:73-110.
33. Schuster EH, Bulkley BH. Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation 1979; 60: 1532-1538.
34. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
35. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 1999;41:586-593.
36. Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol 1991;68:1D-6D.
37. Yin FC. Ventricular wall stress. Circ Res 1981;49:829-842.
38. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986; 74:693-702.
39. Kloner RA, Hwang H. New insights into the open artery hypothesis. Circ Res 2008; 103:1-3.
40. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75:299-306.
41. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 1988; 116:1508-1513.
42. Nakagawa M, Takemura G, Kanamori H, Goto K, Maruyama R, Tsujimoto A et al. Mechanisms by which late coronary reperfusion mitigates postin- farction cardiac remodeling. Circ Res 2008;103:98-106.
43. Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose- dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983;68:446-452.
44. Hammerman H, Schoen FJ, Braunwald E, Kloner RA. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation 1984;69:611-617.
45. Monden Y, Kubota T, Tsutsumi T, Inoue T, Kawano S, Kawamura N et al. Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction. Cardiovasc Res 2007;73:794-805.
46. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda Met al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004;109:2572-2580.
47. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of cap- topril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-86.
48. Pirzada FA, Weiner JM, Hood WB Jr. Experimental myocardial infarction. 14. Accelerated myocardial stiffening related to coronary reperfusion following ischemia. Chest 1978;74:190-195.
49. Uusimaa P, Risteli J, Niemela M, Lumme J, Ikaheimo M, Jounela A et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997;96:2565-2572.
50. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix. When is enough enough? Circulation 2003;108: 1395-1403.
51. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992;20:3-16.
52. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 1974;35:17-26.
53. Nag AC. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 1980;28:41-61.
54. Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Zern MA, Seifter S et al. Collagen chain mRNAsin isolated heart cells from young and adult rats. J Mol Cell Cardiol 1988;20:267-276.
55. Hayakawa K, Takemura G, Kanoh M, Li Y, Koda M, Kawase Y et al. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003;108:104-109.
56. Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S et al. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 2004;95:627-636.
57. von Harsdorf R. 'Fas-ten' your seat belt: anti-apoptotic treatment in heart failure takes off. Circ Res 2004;95:554-556.
58. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
59. Kloner RA. Coronary angioplasty: a treatment option for left ventricular remodeling after myocardial infarction? J Am Coll Cardiol 1992;20:314-316.
60. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postis- chemic ventricular dysfunction. Circulation 1982;66:1146-1149.
61. Elsässer A, Schlepper M, Klôvekorn WP, Cai WJ, Zimmermann R, Muller KD et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-2931.
62. Elsässer A, Vogt AM, Nef H, Kostin S, Möllmann H, Skwara Wet al. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol 2004;43:2191-2199.
63. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH et al. Autop- hagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102:13807-13812.
64. Molkentin JD, Kalvakolanu DV, Markham BE. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy- chain gene. Mol Cell Biol 1994;14:4947-4957.
65. Murphy AM, Thompson WR, Peng LF, Jones L 2nd. Regulation of the rat cardiac troponin I gene by the transcription factor GATA-4. Biochem J 1997;322:393-401.
66. Abbate A, Bussani R, Biondi-Zoccai GG, Rossiello R, Silvestri F, Baldi F et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation 2002;106:1051-1054.
67. Baldi A, Abbate A, Bussani R, Patti G, Melfi R, Angelini A et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 2002; 34:165-174.
68. Takemura G, Fujiwara H. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 2006;10:56-75.
69. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013-3026.
70. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007;14:1237-1243.
71. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
72. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
73. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
74. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
75. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
76. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100:14-20.
77. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-585.
78. EMERAS (Estudio Multicéntrico Estreptoquinasa Repéblicas de América del Sur) Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767-772.
79. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-766.
80. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML et al. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation 1992;85:2090-2099.
81. Dzavik V, Beanlands DS, Davies RF, Leddy D, Marquis JF, Teo KK et al. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (>6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]-a pilot study). Am J Cardiol 1994;73:856-861.
82. Horie H, Takahashi M, Minai K, Izumi M, Takaoka A, Nozawa M et al. Long- term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998;98:2377-2382.
83. Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002;40:869-876.
84. Steg PG, Thuaire C, Himbert D, Carrieé D, Champagne S, Coisne D et al.; DECOPI Investigators. DECOPI (DEsobstruction COronaire en PostInfarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004;25:2187-2194.
85. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ et al., for the Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355:2395-2407.
86. Davik V, Buller CE, Lamas GA, Rankin JM, Mancini GBJ, Cantor WJ et al., for the TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary occlusion to achieve long-term patency and improve ventricular function. The Total Occlusion Study of Canada (TOSCA)-2 Trial. Circulation 2006;114:2449-2457.
87. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: two-dimensional echocardiography. N Engl J Med 1979;300:57-62.
88. Hamon M, Bauters C, McFadden EP, Wernert N, Lablanche JM, Dupuis B et al. Restenosis after coronary angioplasty. Eur Heart J 1995;16(Suppl. I):33-48.
89. Bass TA. Post-PCI cardiac events? The answer is the lumen, or is it in the wall? Catheter Cardiovasc Interv 2002;55:338-339.
90. Kivelä A, Hartikainen J. Restenosis related to percutaneous coronary intervention has been solved? Ann Med 2006;38:173-187.